A Comprehensive Assessment of <sup>68</sup>Ga-PSMA-11 PET in Biochemically Recurrent Prostate Cancer: Results from a Prospective Multicenter Study on 2,005 Patients.

导出 OA

翻译打印收藏纠错

第一作者： Monica,Abghari-Gerst

第一单位： Radiology Department, University of Michigan, Ann Arbor, Michigan.

作者： Monica,Abghari-Gerst ^[1] ; Wesley R,Armstrong ^[2] ; Kathleen,Nguyen ^[2] ; Jeremie,Calais ^[2] ; Johannes,Czernin ^[2] ; David,Lin ^[3] ; Namasvi,Jariwala ^[3] ; Melissa,Rodnick ^[1] ; Thomas A,Hope ^[3] ; Jason,Hearn ^[4] ; Jeffrey S,Montgomery ^[5] ; Ajjai,Alva ^[6] ; Zachery R,Reichert ^[6] ; Daniel E,Spratt ^[4] ; Timothy D,Johnson ^[7] ; Peter J H,Scott ^[1] ; Morand,Piert ^[8]

作者单位： Radiology Department, University of Michigan, Ann Arbor, Michigan. ^[1] Ahmanson Translational Theranostics Division, Department of Molecular and Medical Pharmacology, UCLA, Los Angeles, California. ^[2] Department of Radiology and Biomedical Imaging, University of California San Francisco, San Francisco, California. ^[3] Department of Radiation Oncology, University of Michigan, Ann Arbor, Michigan. ^[4] Urology Department, University of Michigan, Ann Arbor, Michigan. ^[5] Internal Medicine Department, University of Michigan, Ann Arbor, Michigan; and. ^[6] Department of Biostatistics, University of Michigan, Ann Arbor, Michigan. ^[7] Radiology Department, University of Michigan, Ann Arbor, Michigan; mpiert@med.umich.edu. ^[8]

关键词 PSMA disease pattern hybrid PET prostate cancer prostate-specific membrane antigen